Open AccessDrug and others products shortage in Brazilian health services in the scenario imposed by COVID-19
Author(s) -
Marcelo Rodrigues Martins,
Valéria Santos Bezerra,
Flávia Neri Meira de Oliveira,
Alice Ramos Oliveira Silva,
Elisângela da Costa Lima
Publication year - 2022
Publication title -
research, society and development
Language(s) - English
Resource type - Journals
ISSN - 2525-3409
DOI - 10.33448/rsd-v11i5.27928
Subject(s) - pandemic , economic shortage , medicine , covid-19 , descriptive statistics , univariate , business , public health , family medicine , nursing , disease , multivariate statistics , statistics , infectious disease (medical specialty) , government (linguistics) , linguistics , philosophy , mathematics
Objective: We aimed at investigating and describing the drug and material resources in health shortage in the Brazilian services during the COVID-19 pandemic. Methods: We conducted a cross-sectional study in the format of an online survey with closed questions. Information was sought about the institutional and care profile, pharmaceutical service organization, non-compliance in the stock, or lack of drugs and other health products between April and October 2020. We performed descriptive, univariate, and multivariate statistical analyses, such as Fisher's t-test, chi-square test, and the Multiple Correspondence and Hierarchical Cluster analyses. A p-value below 0.05 and a 95% significance level were considered. Results: 228 Brazilian institutions, most located in the capital cities, with specific beds for COVID-19 and public administration, were included in the study. Grouping by similarity separated the study sample into five heterogeneous clusters. Eighty-four percent of the services indicated a drugs shortage, especially neuromuscular blocking agents (64.9%), hypnotics and sedatives (52.9%), vasoactive drugs (37.3%), and antiinfective agents (30%). Conclusion: In all the clusters, there were reports of a shortage of items considered essential in the management of critically-ill patients, corroborating the perception that this was a significant challenge for pharmaceutical assistance in various Brazilian services during the COVID-19 pandemic.